04566nam 2200589 450 991081514060332120230421054916.03-11-090666-X10.1515/9783110906660(CKB)3390000000034404(SSID)ssj0000849216(PQKBManifestationID)11536277(PQKBTitleCode)TC0000849216(PQKBWorkID)10813553(PQKB)10709800(MiAaPQ)EBC3042712(DE-B1597)40776(OCoLC)979764905(DE-B1597)9783110906660(Au-PeEL)EBL3042712(CaPaEBR)ebr10754877(OCoLC)922945714(EXLCZ)99339000000003440419960311d1996 uy 0engurcnu||||||||txtccrConcepts in vaccine development /editor, Stefan H.E. KaufmannReprint 2012Berlin ;New York :Walter de Gruyter,1996.1 online resource (605 pages) illustrationsBibliographic Level Mode of Issuance: Monograph3-11-178051-1 3-11-014815-3 Includes bibliographical references and index.Front matter --Preface --Bicentennial of the first vaccination by Edward Jenner /Kaufmann, Stefan H.E. --Contents --1. The Need for New Vaccines --1.1. Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy /Ewald, Paul W. --1.2. Economic Perspectives on Vaccine Needs /Ashley, Robert V. / Murray, Christopher J. L. --1.3. Future Immunization Strategies - Considerations from the Public Health View /Dittmann, Sieghart --1.4. The New Pertussis Vaccines /Klein, David L. / Heilman, Carole --2. General Principles of Immunology --2.1. Basic Principles of Immunity Against Intracellular Bacteria and Protozoa /Szalay, Gudrun / Kaufmann, Stefan H. E. --2.2. Viral Immunity and Vaccine Strategies /Woodland, David L. / Cole, Geoffrey A. / Doherty, Peter C. --2.3. Broadly Reactive HLA Restricted Τ Cell Epitopes and Their Implications for Vaccine Design /Sidney, John / Kubo, Ralph T. / Wentworth, Peggy A. / Alexander, Jeff / Chesnut, Robert W. / Grey, Howard M. / Sette, Alessandro --2.4. Quantitative Considerations in the Design of Vaccination Strategies Against Pathogens Uniquely Susceptible to Cell-Mediated Attack /Bretscher, Peter --2.5. The Impact of the Type 1 and Type 2 Τ Helper Cell Concept on Novel Vaccine Design with Emphasis on Protection Against Leishmania Parasites /Bogdan, Christian / Röllinghoff, Martin --3. General Principles of Vaccinology --3.1. Modern Adjuvants. Functional Aspects /Morein, Bror / Lövgren-Bengtsson, Karin / Cox, John --3.2. Biodegradable Microspheres as Vehicles for Antigens /Kersten, Gideon F.A. / Gander, Bruno --3.3. Peptide Based Vaccines /Schild, Hansjörg / Rammensee, Hans-Georg --3.4. Recombinant Bacteria as Vaccine Carriers of Heterologous Antigens /Hormaeche, Carlos E. / Khan, C. M. Anjam --3.5. Genetic Detoxification of Bacterial Toxins /Rappuoli, Rino / Pizza, Mariagrazia --3.6. Recombinant Virus as Vaccination Carrier of Heterologous Antigens /Perkus, Marion E. / Paoletti, Enzo --3.7. Naked DNA Vaccination /Shiver, John W. / Ulmer, Jeffrey B. / Donnelly, John J. / Liu, Margaret A. --3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin /Holmgren, Jan / Czerkinsky, Cecil / Sun, Jia-Bin / Svennerholm, Ann-Mari --4. Specific Vaccination Strategies --4.1. Helicobacter pylori: Pathogenic Determinants and Strategies for Vaccine Design /Ghiara, Paolo / Covacci, Antonello / Telford, John L. / Rappuoli, Rino --4.2. Malaria Vaccination /Patarroyo, Manuel E. / Amador, Roberto --4.3. Vaccination Against Schistosomiasis: Concepts and Strategies /Riveau, Gilles J. / Capron, André --4.4. AIDS Vaccination /Norley, Stephen / Kurth, Reinhard --4.5. Vaccination Therapy Against Autoimmune Diseases /Cohen, Irun R. / Mor, Felix --Contributors --IndexVaccinesImmunizationVaccines.Immunization.615/.372XD 3300rvkKaufmann S. H. E(Stefan H. E.)42605MiAaPQMiAaPQMiAaPQBOOK9910815140603321Concepts in vaccine development3925731UNINA